Skip to content
value.today

IRulya Therapeutics Inc. vs EyePoint Pharmaceuticals, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • IRulya Therapeutics Inc. and EyePoint Pharmaceuticals, Inc. are worth about the same: $343 M and $349 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 14, 2026 for EyePoint Pharmaceuticals, Inc.).
  • Both made a net loss: $84 M for IRulya Therapeutics Inc. and $232 M for EyePoint Pharmaceuticals, Inc.
  • EyePoint Pharmaceuticals, Inc. employs more people: 123 against 55 at IRulya Therapeutics Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01933865797722020202120222023202420252026IRulya Therapeutics Inc. 23EyePoint Pharmaceuticals, Inc. 207

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025EyePoint Pharmaceuticals, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureIRulya Therapeutics Inc.
IRLA · #14,187 in the world
EyePoint Pharmaceuticals, Inc.
EYPT · #14,107 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—1987
Size
Market cap$343 M$349 M
Revenue—$31 M
Net income$-84 M▲ best$-232 M
Employees55123
Valuation
Price to sales—11.1×
Price to book—1.1×
Free cash flow yield-12.2%▲ best-69.7%
Profitability
Operating margin—-776.0%
Net margin—-739.4%
Return on equity—-72.2%
Growth
Revenue growth—-27.5%
Revenue growth, 3 years a year—-8.8%
Cash
Free cash flow margin—-775.9%
Altman Z-score zone—distress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?

IRulya Therapeutics Inc. and EyePoint Pharmaceuticals, Inc. are worth about the same: $343 M and $349 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 14, 2026 for EyePoint Pharmaceuticals, Inc.).

Which makes more money, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?

Both made a net loss: $84 M for IRulya Therapeutics Inc. and $232 M for EyePoint Pharmaceuticals, Inc.

Which has more employees, IRulya Therapeutics Inc. or EyePoint Pharmaceuticals, Inc.?

EyePoint Pharmaceuticals, Inc. employs more people: 123 against 55 at IRulya Therapeutics Inc.